Health
SARS-CoV-2 D614G mutation does affect performance of serological assays – News-Medical.Net
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared…
In a new study published in The Journal of Infectious Diseases, US researchers considered the emergence of a new SARS-CoV-2 spike protein variant. They compared spike G614-based assay to the original D614-based assay – pointing towards the development of recognizable, cross-responsive humoral immunity.
The need to understand the coronavirus disease (COVID-19) pandemic caused by the SARS-CoV-2 has turned our eye towards the acquisition and development of population immunity. We know that the human…
-
Noosa News22 hours agoDid you lose your ring?
-
Business24 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News20 hours agoThe only person detained at Brisbane’s Palestine rally
-
Business19 hours agoHow to turn $500 a month into $500,000 with ASX shares